जीन एडिटिंग की संपूर्ण मार्गदर्शिका।
मेनू
होम जानें समाचार Atlas से पूछें
अन्वेषण करें तकनीकें रोग उपचार क्लिनिकल ट्रायल्स कंपनियाँ वैज्ञानिक Genes शोध संस्थाएँ
चिकित्सा से परे कृषि नैतिकता निवेश विश्व मानचित्र
जानें और टूल्स यहाँ से शुरू करें शब्दावली A–Z तकनीकों की तुलना करें समयरेखा सूचियाँ और रैंकिंग AI एजेंट्स ★ सहेजा गया API
के बारे में हमारे बारे में कार्यपद्धति डेटा स्रोत संपादकीय नीति संपर्क करें अस्वीकरण

🧭 निर्देशित दृश्य
जेनेटिक्स में नए हैं? ब्राउज़ करते समय हम हर शब्द को सरल भाषा में समझाते हैं। वही पेज, बस मदद पहले से मौजूद।

⚡ विशेषज्ञ दृष्टिकोण
आप जीव विज्ञान पहले से जानते हैं। बस सामग्री — साफ़ और संक्षिप्त, कोई अतिरिक्त स्पष्टीकरण नहीं। यह डिफ़ॉल्ट व्यू है।

इंटरफ़ेस भाषा
Light mode

Companies

Gene-Editing Companies by Founding Year

The sector in chronological order — which shows how tightly the founding wave clusters around 2013.

यह सूची कैसे बनती है

Sorting companies by when they were founded shows something striking: a cluster in 2013, immediately after CRISPR was shown to work in human cells, and then successive waves as each new technique arrived — base editing companies around 2017, prime editing from 2019.

#प्रविष्टिश्रेणी Foundedस्थिति
1 Eli Lilly and Company A major pharmaceutical company that entered gene editing by acquisition, buying Verve… Large pharmaceutical 1876 Phase II
2 Vertex Pharmaceuticals The established biotechnology company that partnered on, and commercialises, the first… Large biotechnology 1989 Approved
3 Sangamo Therapeutics The company that took gene editing into humans first, years before CRISPR existed as a… Zinc finger platform 1995 Phase III
4 Caribou Biosciences Co-founded by Jennifer Doudna, using hybrid RNA-DNA guides intended to make editing… Cell therapy 2011 Phase I
5 CRISPR Therapeutics Co-founded by Emmanuelle Charpentier, and the company behind the first approved CRISPR… CRISPR-Cas9 platform 2013 Approved
6 Editas Medicine One of the first CRISPR companies, which discontinued its cell-therapy and eye programmes… In vivo editing 2013 Preclinical
7 Intellia Therapeutics Co-founded by Jennifer Doudna, and the company that first delivered CRISPR into a human… In vivo CRISPR platform 2014 Phase III
8 Arbor Biotechnologies Co-founded by Feng Zhang and David Scott to discover new editing enzymes from nature at… Novel editors 2016 Phase I
9 Beam Therapeutics Founded by David Liu and colleagues to commercialise base editing — precision changes to… Base editing platform 2017 Phase III
10 Mammoth Biosciences Co-founded by Jennifer Doudna around ultra-compact CRISPR proteins small enough to fit… Miniature editors and diagnostics 2017 Preclinical
11 Sana Biotechnology Engineering transplanted cells to be invisible to the immune system, so they can be given… Cell engineering 2018 Phase I
12 Scribe Therapeutics Co-founded by Jennifer Doudna to engineer CRISPR enzymes from scratch rather than use the… Engineered editors 2018 Preclinical
13 Tessera Therapeutics Developing 'gene writing' — mobile genetic elements repurposed to insert whole sequences… Gene writing 2018 Preclinical
14 Verve Therapeutics Built to turn heart disease into a one-time treatment, and acquired by Eli Lilly in 2025… In vivo base editing 2018 Phase II
15 Prime Medicine Founded to commercialise prime editing, and the company behind the first published… Prime editing platform 2019 Phase I/II
16 Tune Therapeutics Turning genes up and down without changing sequence — epigenetic editing taken into early… Epigenetic editing 2021 Phase I
यह सूची आपको क्या नहीं बतातीFounding dates are as reported by the companies. This is not a complete census of the sector.
Written by The CRISPR Atlas editorial team Last updated Aug 25, 2026